News
Zacks.com on MSN1h
Corcept Seeks FDA Approval for Relacorilant in Ovarian CancerCORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.
News-Medical.Net on MSN22h
Prostate cancer cells evade ferroptosis by accumulating lipid dropletsA new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback